PT Siloam International Hospitals Tbk.

silo

-2.04%

Overview

SILO Overview

PT Siloam International Hospitals Tbk (Siloam Hospitals) is an Indonesia-based company. The Company's principal activity is engaging in healthcare provision, including setting up and managing hospitals. It offers a range of specialist and general medical services, including surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services. Siloam Hospitals has a capacity of approximately 7,628 beds supported by doctors, which consists of specialists, as well as nurses, health technicians and support staff who provides healthcare. The operation of hospital units of the Company is in several cities on the island of Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat and Bangka. Its subsidiaries include PT Aritasindo Permaisemesta, PT Perdana Kencana Mandiri, PT Multiselaras Anugerah, PT Golden First Atlanta, PT Medika Harapan Cemerlang Indonesia, and PT Kemitraan Syubbanul Wathon Siloam, among others.

5101520ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: SILO

Main
Market Cap.
IDR 31.10Trillion

~$1.94B USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

SILO Valuation Metrics

2,400

IDR
-2.0%

Closing Price on 2024-04-18

Price to Equity

25.68

P/E

At 25.68x P/E TTM, SILO.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 16.9x).

Price to Book

3.93

P/B

At 3.93x P/B TTM, SILO.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 1.7x).

Price to Sales

2.78

P/S

At 2.78x P/S TTM, SILO.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Valuing PT Siloam International Hospitals Tbk. based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Siloam International Hospitals Tbk. relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
14.82x
Price/Forward Earnings
21.93x
Enterprise Value/Revenue
2.72x
Enterprise Value/EBITDA
12.04x
PEG Ratio
0.53x

Analyst Ratings

40
60
80
0
100

82.5

Undervalued

Fairly Valued

Overvalued

Last closing: IDR2,4002024-04-18
IDR 863.53

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of SILO is IDR864, which is 63% lower than SILO's last closing price of IDR2,400 (as of 2024-04-18).

Valuation Recap of SILO stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 25.68x is above the ID market average of 8.46x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (16.91x).

High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 3.93x is above the peers average of 1.69x in the Healthcare Equipment & Providers sector. SILO trades at a higher P/B ratio than >75% of its peers in the Healthcare Equipment & Providers sector.

Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 2.78x is similar to the peers average of 2.87x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of SILO's valuation relative to its current sales and future earnings growth. SILO trades at a Forward P/E ratio of 21.93x, which is considered richly valued by analysts.

Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. SILO's P/CF ratio of 14.82x is considered a relatively high ratio by analysts.

Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. SILO's EV/R ratio of 2.72x is considered fairly underpriced by the market The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.95x.

Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of SILO is IDR 863.53, which is 63% lower than SILO's last closing price of IDR 2,400.00.

Peers

SILO Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk65.45T27.06T 30.45T 2.77T 23.663.06
MIKAPT Mitra Keluarga Karyasehat Tbk.36.85T7.34T 4.26T 0.92T 40.236.33
SILOPT Siloam International Hospitals Tbk.31.10T10.98T 11.19T 1.21T 25.683.93
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.61T 2.50T -0.04T -534.7211.09
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk19.95T3.89T 3.57T 0.95T 20.995.89
HEALPT Medikaloka Hermina Tbk.16.86T8.80T 5.78T 0.44T 38.544.36
PRAYPT Famon Awal Bros Sedaya Tbk9.56T4.70T 1.84T 0.22T 44.073.42
TSPCTempo Scan Pacific Tbk8.66T11.32T 13.12T 1.18T 7.351.12
SOHOPT Soho Global Health Tbk6.24T4.75T 8.20T 0.37T 16.822.60
OMEDPT Jayamas Medica Industri Tbk5.33T2.58T 1.74T 0.26T 20.552.40
Competitiveness Recap of SILO stock
WeightNotesScore
High
At a market cap of IDR 31,103.52 billion, SILO.JK ranks 3 in Market Cap out of 10 companies in the Healthcare sector.

High
At a PE of 25.68, SILO.JK ranks 4 out of 10 companies in the Healthcare sector for P/E value. The average PE is -29.68 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. In this regard, it trails behind sector leaders such as PT Famon Awal Bros Sedaya Tbk (44.07) in the Healthcare sector.

Medium
At a PE of 25.68, SILO.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 16.91). false

Medium
At a revenue of IDR 11.19 trillion, SILO.JK ranks 3 in Revenue out of 10 companies in the Healthcare sector.

Medium
At a profit of IDR 1.21 trillion, SILO.JK ranks 2 in Profit out of 10 companies in the Healthcare sector.

Future

Future Growth of SILO

Growth Forecasts

SILO 2024 Revenue Growth
+8.3%
SILO 2024 EPS Growth
-0.9%
Sector Revenue Growth
+9.8%
Healthcare Equipment & Providers
Indonesia Market Growth
+7.6%
IDX overall growth
Healthcare Equipment & Providers Sector Revenue Growth '24
+9.5%
Healthcare Sector Revenue Growth '24
-5.8%

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 9.82% against the IDX average of +7.6%.

Healthcare Equipment & Providers sector overview

SILO Earnings & Revenue Forecast

All values in IDR billion

Future growth prospect of SILO
WeightNotesScore
High
SILO's projected growth rate of 9.82% is above the ID market average of 7.62%.

Medium
SILO and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a challenging year heading into 2024. Specifically, earnings are projected to decrease by 0.00% in 2024 while revenue growth is projected to decrease by -5.79%. These macroeconomic trends will likely be a headwind for SILO's earnings growth prospects in the next 2 years.

Loading...
Loading...

Management

Executive Management

President Director

Benny Haryanto Djie15.2 years

Vice President Director

-15.4 years
Dr. Grace Frelita Indradjaja
Director
Dr. Anang Prayudi
Director
Atiff Ibrahim Gill
Director
Phua Meng Khuan (Daniel Phua)
Director
Hedny Widjaja
Director
Monica Surjapranata
Director
-
Director
NamePositionShares%
No data is available for SILO at the moment.
Expressed in millions IDR, unless otherwise stated

Ownership

SILO Ownership

Others
4.88%
Insiders
91.18%
Institutions
3.94%
NameNumber of SharesOwnership (%)Value
Megapratama Karya Persada, Pt.6,447,348,48049.5715,473.64B
Prime Health Company Limited3,405,587,43226.188,173.41B
Public (Scripless)2,029,715,06815.624,871.32B
Public (Scrip)1,104,834,1208.492,651.60B
Treasury Stock18,639,9000.1444.74B

Largest Institutional Buy

Eastspring Investments (Singapore) Ltd
Bought 31-12-2023
+94,200 shares
PT Eastspring Investment Indonesia
Bought 31-12-2023
+40,600 shares

Largest Institutional Sell

No data is available for SILO at the moment.

Institutional Transactions

Tracking institutional transactions buying / selling of SILO stock